155 related articles for article (PubMed ID: 27617513)
1. Delivery of siRNA Using Lipid Nanoparticles Modified with Cell Penetrating Peptide.
Li Y; Lee RJ; Yu K; Bi Y; Qi Y; Sun Y; Li Y; Xie J; Teng L
ACS Appl Mater Interfaces; 2016 Oct; 8(40):26613-26621. PubMed ID: 27617513
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel nanoparticle by dual modification with the pluripotential cell-penetrating peptide PepFect6 for cellular uptake, endosomal escape, and decondensation of an siRNA core complex.
Mitsueda A; Shimatani Y; Ito M; Ohgita T; Yamada A; Hama S; Gräslund A; Lindberg S; Langel Ü; Harashima H; Nakase I; Futaki S; Kogure K
Biopolymers; 2013 Nov; 100(6):698-704. PubMed ID: 23893316
[TBL] [Abstract][Full Text] [Related]
3. cRGD peptide-conjugated polyethylenimine-based lipid nanoparticle for intracellular delivery of siRNA in hepatocarcinoma therapy.
Yang S; Wang D; Zhang X; Sun Y; Zheng B
Drug Deliv; 2021 Dec; 28(1):995-1006. PubMed ID: 34042551
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid modified octa-arginine for delivery of siRNA.
Li Y; Li Y; Wang X; Lee RJ; Teng L
Int J Pharm; 2015 Nov; 495(1):527-535. PubMed ID: 26386137
[TBL] [Abstract][Full Text] [Related]
5. Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA nanocomplexes for anti-melanoma treatment.
Ruan W; Zhai Y; Yu K; Wu C; Xu Y
Int J Pharm; 2018 Dec; 553(1-2):298-309. PubMed ID: 30347273
[TBL] [Abstract][Full Text] [Related]
6. Cell penetrating peptide-mediated systemic siRNA delivery to the liver.
Hayashi Y; Yamauchi J; Khalil IA; Kajimoto K; Akita H; Harashima H
Int J Pharm; 2011 Oct; 419(1-2):308-13. PubMed ID: 21827843
[TBL] [Abstract][Full Text] [Related]
7. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
8. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
9. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM
Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
[TBL] [Abstract][Full Text] [Related]
12. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
[TBL] [Abstract][Full Text] [Related]
13. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
[TBL] [Abstract][Full Text] [Related]
14. Synergism between a cell penetrating peptide and a pH-sensitive cationic lipid in efficient gene delivery based on double-coated nanoparticles.
Khalil IA; Kimura S; Sato Y; Harashima H
J Control Release; 2018 Apr; 275():107-116. PubMed ID: 29452131
[TBL] [Abstract][Full Text] [Related]
15. In vitro investigations of the efficacy of cyclodextrin-siRNA complexes modified with lipid-PEG-Octaarginine: towards a formulation strategy for non-viral neuronal siRNA delivery.
O'Mahony AM; Desgranges S; Ogier J; Quinlan A; Devocelle M; Darcy R; Cryan JF; O'Driscoll CM
Pharm Res; 2013 Apr; 30(4):1086-98. PubMed ID: 23192687
[TBL] [Abstract][Full Text] [Related]
16. Improving the efficacy of liposome-mediated vascular gene therapy via lipid surface modifications.
Fisher RK; Mattern-Schain SI; Best MD; Kirkpatrick SS; Freeman MB; Grandas OH; Mountain DJH
J Surg Res; 2017 Nov; 219():136-144. PubMed ID: 29078873
[TBL] [Abstract][Full Text] [Related]
17. Liquid Crystalline Nanodispersions Functionalized with Cell-Penetrating Peptides for Topical Delivery of Short-Interfering RNAs: A Proposal for Silencing a Pro-Inflammatory Cytokine in Cutaneous Diseases.
Petrilli R; Eloy JO; Praça FS; Del Ciampo JO; Fantini MA; Fonseca MJ; Bentley MV
J Biomed Nanotechnol; 2016 May; 12(5):1063-75. PubMed ID: 27305826
[TBL] [Abstract][Full Text] [Related]
18. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
[TBL] [Abstract][Full Text] [Related]
20. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery.
Yang Y; Yang Y; Xie X; Wang Z; Gong W; Zhang H; Li Y; Yu F; Li Z; Mei X
Biomaterials; 2015 Apr; 48():84-96. PubMed ID: 25701034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]